stockrow
Saturday 7 November 2026
Export LXRX’s income statement to Excel — free account
Lexicon Pharmaceuticals, Inc.
LXRX Healthcare Biotechnology
Lexicon Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $49.8 million, up 60.2% from fiscal 2024.
- Revenue
- −20.7%
- EPS
- +21.3%
- Free cash flow
- +66.1%
- Total debt
- −8.17%
Quarter to September 2026, against a year earlier
1.79
0.18
+11.18%
Follow LXRX
Alert me
Lexicon Pharmaceuticals, Inc. (LXRX) P/E ratio
Lexicon Pharmaceuticals, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 11.9× (September 2021) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 3.4× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 11.9×
Ten-year median
0.0×
Current reading's percentile
89
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| DNA Ginkgo Bioworks Holdings, Inc. compare | n/m |
| SANA Sana Biotechnology, Inc. compare | n/m |
| SLDB Solid Biosciences Inc. compare | n/m |
| LXRX Lexicon Pharmaceuticals, Inc. | n/m |
| OABI OmniAb, Inc. compare | n/m |
| ARDX Ardelyx, Inc. compare | n/m |
| ANNX Annexon, Inc. compare | n/m |
| CGEM Cullinan Therapeutics, Inc. compare | n/m |
| ATTO Attovia Therapeutics, Inc. compare | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)